C07D 271/04
1,2,3-oxadiazoles
Official title: 1,2,3-Oxadiazoles; Hydrogenated 1,2,3-oxadiazoles
C07D271/04 (1,2,3-oxadiazoles) appears on 78 US grants and 68 published applications in this corpus.
Search patents in C07D- Granted patents
- 78
- Published applications
- 68
- Assignees
- 57
- Inventors
- 276
- Latest grant
- 3 Jun 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 4 | 0 |
| 1982 | 2 | 0 |
| 1983 | 4 | 0 |
| 1984 | 4 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 2 | 0 |
| 1990 | 2 | 0 |
| 1991 | 1 | 0 |
| 1992 | 4 | 0 |
| 1993 | 2 | 0 |
| 1994 | 1 | 0 |
| 1995 | 2 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 1 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 0 | 1 |
| 2009 | 0 | 4 |
| 2010 | 1 | 0 |
| 2011 | 0 | 3 |
| 2012 | 1 | 3 |
| 2013 | 2 | 4 |
| 2014 | 3 | 5 |
| 2015 | 7 | 4 |
| 2016 | 2 | 5 |
| 2017 | 2 | 6 |
| 2018 | 4 | 5 |
| 2019 | 3 | 7 |
| 2020 | 7 | 6 |
| 2021 | 5 | 2 |
| 2022 | 5 | 5 |
| 2023 | 2 | 2 |
| 2024 | 1 | 3 |
| 2025 | 1 | 1 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Alkene-containing amide compound and application thereof3 Jun 2025US 12,319,663 B2Jiangsu Yangnong Chemical Co., Ltd.
- Methods of treating dyskinesia and related disorders30 Jul 2024US 12,048,697 B2Melior Pharmaceuticals II, LLC
- Viral replication inhibitors31 Jan 2023US 11,566,025 B2Katholieke Universiteit Leuven
- Drugs and compositions for the treatment of ocular disorders10 Jan 2023US 11,548,861 B2Graybug Vision, Inc.
- Aromatic sulfonamide derivatives13 Dec 2022US 11,524,938 B2Bayer Pharma Aktiengesellschaft
- Dihydroindene derivatives as malt1 inhibitors2 Jul 2026US 2026/0184687 A1C4X Discovery Limited
- Flavivirus inhibitors20 Nov 2025US 2025/0353853 A1C.N.C.C.S. S.C.A.R.L. Collezione Nazionale Dei Composti Chimici E Centro Screening
- Methods Of Treating Dyskinesia And Related Disorders12 Dec 2024US 2024/0408090 A1Melior Pharmaceuticals II, LLC
- Branched tail lipid compounds and compositions for intracellular delivery of therapeutic agents11 Jul 2024US 2024/0226026 A1ModernaTX, Inc.
- Drugs and compositions for the treatment of ocular disorders21 Mar 2024US 2024/0092745 A1Graybug Vision, Inc.
Most cited
By later US patents
- Nitric oxide donor neprilysin inhibitors53US 9,045,443 B2Theravance Biopharma R&D IP, LLC · 2015
- Calpain modulators and therapeutic uses thereof16US 10,934,261 B2Blade Therapeutics, Inc. · 2021
- Hydroxyl protected 3-(2-hydroxy-2-phenylethyl)-N-[(phenylamino)carbonyl]sydnone imine intermediates12US 4,446,322 AAmerican Home Products Corporation · 1984
- Phthalamide derivatives, intermediates in the production thereof, and agricultural/horticultural insecticides and method for using the same11US 6,875,768 B1Nihon Nohyako Co., Ltd. · 2005
- CNS Stimulants9US 4,371,539 AAmerican Home Products Corporation · 1983